NCT03022461View on ClinicalTrials.gov

HeartMate 3 CE Mark Study Long Term Follow-up

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

June 23, 2014

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions
Advanced Refractory Left Ventricular Heart Failure
Interventions
OTHER

Long term follow-up

Trial Locations (8)

4

Institute for Clinical and Experimental Medicine (IKEM), Prague

3000

The Alfred Hospital, Melbourne

13353

Deutsches Herzzentrum Berlin, Berlin

30625

Medizinische Hochschule Hannover, Hanover

79106

Universitats-Herzzentrum Freiburg, Freiburg im Breisgau

A-1090

AKH Medical University of Vienna, Vienna

M5G2C4

Toronto General Hospital, Toronto

010000

National Research Center for Cardiac Surgery, Astana

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT03022461 - HeartMate 3 CE Mark Study Long Term Follow-up | Biotech Hunter | Biotech Hunter